Integra LifeSciences IART Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 50.9%-3.9pp | 54.8%-2.6pp | 57.4%-4.9pp | 62.3%+1.0pp | |
| Operating margin | -31.6%-33.3pp | 1.8%-5.5pp | 7.2%-8.1pp | 15.3%+2.6pp | |
| Net margin | -31.6%— | —— | 4.4%-7.2pp | 11.6%+0.6pp | |
| Returns | |||||
| Return on equity | -39.9%— | —— | 4%-6.4pp | 10.3%-0.2pp | |
| Return on invested capital | -17.6%-18.7pp | 1%-3.0pp | 4.1%-5.2pp | 9.3%+1.8pp | |
| Efficiency | |||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Liquidity | |||||
| Current ratio | 2.5×+1.4× | 1.2×-2.3× | 3.4×-0.2× | 3.6×+0.2× | |
| Leverage | |||||
| Debt-to-equity | 1.8×+0.6× | 1.2×+0.6× | 0.6×+0.1× | 0.5×0.0× | |
| Per Share | |||||
| Book value per share | $13.61-32.2% | $20.07+1.5% | $19.77-8.5% | $21.61+9.6% | |
| Valuation | |||||
| Market capitalization | $1.38B+53.4% | $1.75B-48.7% | $3.41B-27.2% | $4.68B-17.5% | |
| Price / sales | 0.8×+0.3× | 1.1×-1.1× | 2.2×-0.8× | 3×-0.7× | |
| Price / book | 1.3×+0.7× | 1.1×-1.0× | 2.1×-0.4× | 2.6×-0.8× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Integra LifeSciences's profit margins?
- Integra LifeSciences (IART) runs a 51.9% gross margin and a -29.8% operating margin, with a -30.1% net margin.
- Where do Integra LifeSciences's ratios come from?
- Every ratio is computed from Integra LifeSciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
